华大基因：关于控股股东一致行动人股权结构变动暨完成工商变更登记的提示性公告

Core Viewpoint - BGI Genomics announced a change in the shareholding structure of its controlling shareholder, Huada San Sheng Yuan, with a 5% stake transferred from individual shareholder Li Songgang to Shenzhen Huada Technology Enterprise Management Co., controlled by Wang Jian [1] Group 1 - BGI Genomics received a notification regarding the adjustment in the shareholding structure of its controlling shareholder [1] - The transfer of 5% equity was completed on July 28, 2025, with the relevant business registration changes finalized [1] - The actual controller of the transferred shares is Wang Jian, indicating a consolidation of control within the company [1]